Skip to main content

MoneyWorks4Me

Combat Drugs informs about quarterly statement of investor complaints

04 Jan 2017 Evaluate

Combat Drugs has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1864.10
Dr. Reddys Labs. 1365.75
Cipla 1401.25
Lupin 1983.65
Zydus Lifesciences 1201.70
View more..